Lendacin 250 mg prašek za raztopino za injiciranje/infundiranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lendacin 250 mg prašek za raztopino za injiciranje/infundiranje

lek d.d. - ceftriakson - prašek za raztopino za injiciranje/infundiranje - ceftriakson 250 mg / 1 viala - ceftriakson

Lendacin 250 mg prašek za raztopino za injiciranje/infundiranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lendacin 250 mg prašek za raztopino za injiciranje/infundiranje

lek d.d. - ceftriakson - prašek za raztopino za injiciranje/infundiranje - ceftriakson 250 mg / 1 viala - ceftriakson

Lendacin 250 mg prašek za raztopino za injiciranje/infundiranje Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lendacin 250 mg prašek za raztopino za injiciranje/infundiranje

lek d.d. - ceftriakson - prašek za raztopino za injiciranje/infundiranje - ceftriakson 250 mg / 1 viala - ceftriakson

Eucreas Evropska unija - slovenščina - EMA (European Medicines Agency)

eucreas

novartis europharm limited - vildagliptin, metformin hidroklorid - diabetes mellitus, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Icandra (previously Vildagliptin / metformin hydrochloride Novartis) Evropska unija - slovenščina - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - vildagliptin, metformin hidroklorid - diabetes mellitus, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 in 5. 1 za razpoložljive podatke o različnih kombinacijah).

Zomarist Evropska unija - slovenščina - EMA (European Medicines Agency)

zomarist

novartis europharm limited  - vildagliptin, metformin hidroklorid - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.